Zaprinast raises glucose utilisation in SHR skeletal muscle.
Young
M E
ME
Department of Biochemistry, University of Oxford.
Clark
J F
JF
Leighton
B
B
D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D005947:Glucose / Q000378:metabolism*; D006003:Glycogen / Q000096:biosynthesis; D006019:Glycolysis / Q000187:drug effects; D007333:Insulin Resistance; D007773:Lactates / Q000378:metabolism; D018482:Muscle, Skeletal / Q000187:drug effects / Q000378:metabolism*; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology*; D011688:Purinones / Q000494:pharmacology*; D051381:Rats; D011918:Rats, Inbred SHR
D007773:Lactates; D010726:Phosphodiesterase Inhibitors; D011688:Purinones; D006003:Glycogen; C011145:zaprinast; D005947:Glucose